Stocks

USFDA inspects Solara Active Pharma's Cuddalore facility

| Updated on July 08, 2019 Published on July 08, 2019

Solara Active Pharma Science on Monday announced the successful completion of the USFDA inspection at the multi-product manufacturing facility at Cuddalore with zero 483 inspectional observations.

The Cuddalore facility was established in 1991 and is equipped with appropriate infrastructure to include several independent production blocks and related packaging sections, it said in a release to the exchanges.

The site is inspected by various Regulatory Authorities, including the USFDA, MHRA, EDQM, WHO, PMDA, TGA, KFDA, and COFEPRIS. The current USFDA inspection at the facility was scheduled and completed between July 1 and July 5. The stock slipped 2.14 per cent at ₹435.90.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on July 08, 2019
This article is closed for comments.
Please Email the Editor